Home CIN2001
Volver al Inicio CIN2001
Voltar ao inicio CIN2001

RENAL PHYSIOLOGY

• CELL CYCLE REGULATION OF RENAL HYPERTROPHY.
  Gunter Wolf, MD
  Assistant Professor at the Department of Medicine, Division Nephrology and Osteology, University of Hamburg,
  Hamburg, Germany

• ADRENOMEDULINA
  Dr. Aleix Cases
  Hospital Clínic i Provincial Universidad de Barcelona. Barcelona. España

• AQUAPORINS, MOLECULAR PLAYERS IN THE URINARY CONCENTRATION MECHANISM.
  Dra. Patricia Fernández-Llama
  Laboratorio de Hormonologia, Hospital Clinic i Provincial, Universidad de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS),
  Barcelona. España


PROGRESSION OF RENAL DISEASE



• PROGRESIÓN DE LA INSUFICIENCIA RENAL CRÓNICA Y ESTRÉS OXIDATIVO
  
• PROGRESSION OF CHRONIC RENAL FAILURE AND OXIDATIVE STRESS
  Basilia González MD
  Hospital General Yagüe. Burgos. España

• STRATIGIES TO RETARD PROGRESSION OF CHRONIC KIDNEY DISEASE
  Malvinder S. Parmar MD, FRCPC, FACP
  Director of Nephrology, Coordinator, CME, Timmins & District Hospital
  Timmins, ON., Canada.


CLINICAL NEPHROLOGY

• BASIS FOR HYPERNATREMIA IS REVEALED BY A TONICITY BALANCE BUT NOT BY AN ELECTROLYTE-FREE WATER BALANCE
  Ana PCP Carlotti¹ MD, Desmond Bohn² MB, Mogamat Razeen Davids³, J-P Mallie⁴ MD, Mitchell L. Halperin⁵ MD.
  ¹ Department of Pediatrics, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  ²Department of Critical Care Medicine, Hospital for Sick Children, Toronto, Canada
  ³Nephrology Unit and Department of Internal Medicine, University of Stellenbosch, Cape Town, South Africa
  ⁴Renal Division, Hôpital d’Enfants, CHU-Nancy, France
  ⁵Renal Division, St. Michael’s Hospital, University of Toronto, Canada

• ESTADOS HIPOSMOLARES
  Juan Carlos Ayus, M.D. F.A.C.P.
  Baylor College of Medicine. Houston, TX, USA

• UPDATE ON DIETARY RECOMMENDATIONS AND MEDICAL TREATMENT OF RENAL STONE DISEASE
  Ita Pfeferman Heilberg, M.D., PhD
  Associate Professor of the Nephrology Division. Universidade Federal de São Paulo (UNIFESP)
  São Paulo, Brazil.

• COX-2 INHIBITORS AND NEPHROTOXICITY
  Prof. J.Balasubramaniam, M.D.,D.M.
  Kidney Care Center. Tirunelveli, Tamilnadu, India

• ANTIHYPERTENSIVE THERAPY: BETA-BLOCKERS AND DIURETICS - WHY DO PHYSICIANS NOT ALWAYS FOLLOW GUIDELINES?
  Prof. Franz H. Messerli
  Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans. USA.


GLOMERULOPATHIES

• MICROANGIOPATIA TROMBOTICA, SINDROME UREMICO HEMOLITICO Y PURPURA TROMBOTICA TROMBOCITOPENICA
  Piero Ruggenenti M.D.*°, Carlos Chiurchiu M.D.°, Giuseppe Remuzzi M.D.*°
  * Division of Nephrology and Dialysis, Ospedali Riuniti di Bergamo
  ° "Mario Negri" Institute for Pharmacological Research, Negri Bergamo Laboratories and Clinical Research Center for Rare diseases "Aldo e Cele Daccò"
  Bergamo - Italy

• ACUTE RENAL FAILURE AND ANCA ASSOCIATED VASCULITIS IN THE EDERLY.
  Dra. Assumpta Serra
  Hospital Universitari Germans Trias i Pujol. Badalona
  Barcelona, Spain

• THE MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN).
  LAS GLOMERULONEFRITIS MEMBRANOPROLIFERATIVAS (GNMP).
  Prof. Dr. Ernesto O. Hoffmann
  Department of Pathology.Lousiana State University Medical Center
  New Orleans. USA

• CLASS, ACTIVITY AND CHRONICITY INDICES, AND ALPHA-SM ACTIN EXPRESSION AS PROGNOSTIC FACTORS IN LUPUS NEPHRITIS.
  Cuan Ravinal R, Costa R.S., Pastorello M.T., Coimbra T.M., Coelho E.B., Dantas M., dos Reis M.A.
  Faculdade de Medicina de Ribeirão Preto. Universidade de São Paulo. (FMRP-USP).
  São Paulo.Brazil

• NEFRITIS LUPICA DIAGNOSTICO Y TRATAMIENTO
  Abdías Nicanor Hurtado Aréstegui
  Hospital Arzobispo Loayza.
  President of Sociedad Peruana de Nefrología. Peru.

• RENAL INVOLVEMENT IN MIXED CRYOGLOBULINEMIA
  Franco Ferrario MD
  Renal Immunopathology Center
  San Carlo Borromeo Hospital
  Milan, Italy

• MUTATIONS IN THE COL4A4 AND COL4A3 GENES CAUSE FAMILIAL BENIGN HEMATURIA
  Cèlia Badenas MD, Roser Torra MD
  Fundació Puigvert
  Barcelona, Spain

• RENAL BIOPSY: CLINICAL INDICATIONS.
  Prof. Giorgio Fuiano.
  Divisione di Nefrologia e Dialisi Ospedale Policlinico Universitario "Materdomini"
  Catanzaro, Italy

• SINGLE-CENTER EXPERIENCE AND CURRENT INDICATIONS OF RENAL BIOPSY IN ELDERLY PATIENTS
  Francesca Calero MD, J. Ballarín MD
  Fundació Puigvert
  Barcelona, Spain

• SAL, HIPERTENSIÓN Y RIESGO CARDIOVASCULAR
  Pedro Abáigar MD PhD.
  Oscar García Uriarte, MD
  Nefrología. Hospital General Yagüe.
  Burgos. España.

• CASUAL BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE. MEASUREMENT IN CHILDREN
  Dra. Vera Koch,
  Serviço de Nefrologia do Instituto da Criança do Hospital das Clínicas de São Paulo
  São Paulo. Brazil

• AMBULATORY MONITORING OF QKD TO ASSESS ARTERIAL DISTENSIBILITY
  Dr. Philippe Gosse
  Bordeaux. Aubervilliers. France

• PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY AND GEOMETRIC MODELLING IN PATIENTS WITH CHRONIC RENAL FAILURE
  N.A.Tomilina, G.V.Volgina, B.T.Bikbov, Yu.V.Perepechyonickh, I.I.Stenina
  Moscow. Russia

• RIESGO CARDIONEFROVASCULAR
  Jordi BoverMD PhD y Montserrat Picazo MD
  Fundacio Puigvert. Barcelona. España


RENOVASCULAR SECTION:



• NEW INSIGHTS INTO THE RENAL FAILURE ASSOCIATED WITH ATHEROSCLEROTIC RENOVASCULAR DISEASE (ARVD)
  Philip Kalra FRCP MD
  Hope Hospital, Salford. UK

• RENOVASCULOPATHIES AND THE RISE OF BLOOD PRESSURE WITH AGE.
  RE Tracy, M.D.
  Professor of Pathology. Louisiana State University Health Science Center. New Orleans. USA


PREDIALYSIS:


ROUND TABLE ON: CLINICAL MANAGEMENT OF PATIENTS IN PREDIALYSIS STATE
MODERADORA: Dra Guillermina Barril Cuadrado.
Unidad de Predialisis. S.Nefrología. Hospital La Princesa. Madrid. España



• UNIDAD PREDIÁLISIS: CONCEPTO DE UNA UNIDAD MULTIDISCIPLINAR PARA LA ATENCIÓN DE PACIENTES CON ENFERMEDAD RENAL CRÓNICA AVANZADA
  Dra Guillermina Barril Cuadrado. Unidad de Predialisis. Hospital La Princesa. Madrid.

• NUTRITION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)
  Dr. Sergio R. Acchiardo. University of Tennesee, Memphis. USA

• RELATIONSHIP BETWEEN DIFFERENTS METHODS TO ASSESS THE GLOMERULAR FILTRATION RATE IN ADVANCED CHRONIC RENAL DISEASE.
  Dr. Secundino Cigarrán Guldrís. Unidad de Predialisis. Hospital La Princesa. Madrid

• ADYNAMIC BONE: MECHANISMS IN THE ELDERLY END-STAGE RENAL DISEASE PATIENTS?
  Dr. Victor Lorenzo Sellares et al. Hospital Universitario de Canarias. Sta Cruz de Tenerife. Spain

• WHEN IT IS TIME TO INITIATE DIALYSIS ?.
  Francisco Caravaca. Hospital Infanta Cristina. Badajoz. Spain


PERITONEAL DIALYSIS:

• PERITONEAL DIALYSIS: BETTER EQUAL OR WORSE THAN HAEMODIALYSIS?.
  Data Worth Knowing Before Choosing a Dialysis Modality
  Elias Thodis (1), Ploumis Passadakis (1), Vassilis Vargemezis (1)
  and Dimitrios G. Oreopoulos (2).
  (1) Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece and
  (2) The Toronto Western Hospital-University Health Network and University of Toronto, (Western Division), Toronto, Ontario, Canada.

• PERITONEAL DIALYSIS ACCESS - IS IT TIME TO MOVE UP?
  Zbylut J. Twardowski, MD, PhD, FACP
  Professor of Medicine Emeritus. Division of Nephrology. Department of Medicine. University of Missouri.
  Columbia, Missouri. USA

• PERITONEAL DIALYSIS SOLUTIONS.
  José Carolino Divino Filho, MD, PhD
  Assoc. Medical Director, Clinical Affairs. Baxter Renal Division Europe.
  Brussels, Belgium

• ULTRAFILTRATION FAILURE IN PERITONEAL DIALYSIS.
  Javier de Arteaga MD
  Hospital Privado.
  Escuela de Postgrado de Nefrología. Universidad Católica de Córdoba.
  Córdoba. Argentina

• ENCAPSULATING SCLEROSING PERITONITIS (ESP). EARLY DIAGNOSIS
  Dr. Rafael Selgas
  Hospital La Princesa. Madrid. España

• LAPAROSCOPIC PLACEMENT OF PERITONEAL DIALYSIS CATHETERS.
  C. Moreno Sanz, MD. PhD., EBSQ.
  JB. Seoane González, MD. PhD .
  Servicio de Cirugía. Hospital General "La Mancha Centro". Alcazar de San Juan
  Ciudad Real. España

• ACUTE ABDOMEN IN PATIENTS WITH PERITONEAL DIALISYS. UTILITY OF LAPAROSCOPY
  Carlos Moreno Sanz, PhD, EBSQ (European Board of Surgery Qualification)
  JB. Seoane González, MD. PhD .
  Servicio de Cirugía. Hospital General "La Mancha Centro". Alcazar de San Juan
  Ciudad Real. España


HEMODIALYSIS



• FEEDBACK CONTROL OF HEMODIALYSIS.
  Roland Pilgram MD and
  Prof. Daniel Schneditz PhD
  Department of Physiology, University of Graz.
  Graz, Austria

• STRESS OXIDATIVO EN HEMODIALISIS: PREVENCION Y ESTRATEGIAS DE TRATAMIENTO.
  Gerardo Torres Torres MD
  Hospital General Yagüe. Burgos. España

• MANEJO POST-OPERATORIO DEL PACIENTE CON HIPERPARATIROIDISMO SECUNDARIO URÉMICO
  Dres. Alberto M. Alles, Héctor R. Hidalgo, Sergio Marinovich
  Instituto Integral de Nefrologia
  San Lorenzo. Republica Argentina

• LA CALIDAD DEL LÍQUIDO DE HEMODIÁLISIS
  Rafael Pérez-García, Patrocinio Rodríguez-Benítez
  Hospital General Universitario Gregorio Marañón
  Madrid. España

• TEMPERATURE AND HEMODIALYSIS
  Daniel Schneditz, Ph.D.
  Institute of Physiology, University of Graz
  Graz, Austria

• DIFFERENCES IN SOLUTE CLEARANCE BETWEEN HIGH FLUX - HIGH EFFICIENCY DIALYSIS AND ON LINE HEMODIAFILTRATION.
  DIFERENCIAS EN ACLARAMIENTOS DE SOLUTOS ENTRE DIALISIS DE ALTO FLUJO – ALTA EFICACIA, Y HDF EN LÍNEA.
  Prof. Dr. Juan García-Valdecasas Valverde
  Universidad de Granada. Granada, España

• IS THERE A NEED FOR ESTABLISHING A FORMAL NEPHROLOGIST-DIRECTED PRIMARY CARE PROGRAM IN DIALYSIS UNITS?
  Khaja H. Mujtaba Quadri, MD and Sameer Omar Huraib, MD
  Division of Nephrology & Hypertension, Department of Medicine King Fahad National Guard Hospital (KFNGH)
  Riyadh, Saudi Arabia


RENAL OSTEODYSTROPHY

• ROLE OF PHOSPHORUS IN THE PATHOGENESIS OF SECUNDARY HYPERPARATHYROIDISM.
  Dr. Mariano Rodríguez Portillo, Antonio Canalejo, Yolanda Almadén Peña.
  Servicio de Nefrología y Unidad de Investigación. Hospital Universitario Reina Sofía. Córdoba. España

• MECHANISMS OF SKELETAL RESISTANCE TO PTH IN UREMIA
  Masafumi Fukagawa, M.D., Ph.D., FJSIM
  Associate Professor and Chief
  Division of Nephrology and Dialysis Center
  Kobe University School of Medicine. Kobe, Japan

• ENFERMEDAD OSEA ADINAMICA E HIPOPARATIROIDISMO RELATIVO EN LA UREMIA
  Juan F. Navarro González, Carmen Mora Fernández
  Servicio de Nefrología y Unidad de Investigación. Hospital Nuestra Señora de Candelaria.
  Santa Cruz de Tenerife. España

• PAPEL DE LA BIOPSIA OSEA EN EL DIAGNOSTICO DE LA OSTEODISTROFIA RENAL
  Dr. José  Ramón Armas Padrón. H.U Virgen Macarena y Facultad de Medicina de la Universidad de Sevilla
  Dr. Carlos Jarava Mantecón
  Centro de Diálisis Virgen de los Reyes. Sevilla. GAMBRO Healthcare. España.
  Sevilla. España


RENAL TRANSPLANTATION

• RENAL TRANSPLANTATION IN CHILDREN LESS THAN 6 YEARS OF AGE
  Prof. Dra. Clotilde Druck Garcia
  Complexo Hospitalar Santa Casa
  Fundação Faculdade Federal de Ciências Médicas de Porto Alegre - Brazil.

• MATHEMATICAL MODELLING AND SIMULATION OF BIOLOGICAL SYSTEMS IN RENAL TRANSPLANTATION AND RENAL DISEASE
  Dr Douglas R McLean
  Centre for Mathematical and Computational Science in Medicine, Glasgow University,
  Glasgow. Scotland. UK

• DONOR SELECTION
  Rubina Naqvi MBBS, MD
  Assistant Professor. Sindh Institute of Urology and Transplantation (SIUT). Dewan Farooque Medical Complex
  Karachi. Pakistan

• USE OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AS A MARKER FOR PREEMPTIVE TREATMENT
  Dr. Lluis Guirado
  Servicio de Nefrología, Fundacio Puigvert,
  Barcelona, España

• UTILIZATION OF SUBOPTIMAL KIDNEYS (AGED DONORS) IN TRANSPLANTATION
  R. Solà MD
  Fundació Puigvert.
  Barcelona. España

• VALOR CLINICO DE LA CARGA VIRAL DEL VIRUS DE EPSTEIN-BARR (VEB) EN EL TRASPLANTE RENAL.

  CLINICAL VALUE OF EPSTEIN-BARR VIRUS (EBV) LOAD IN KIDNEY TRANSPLANTATION.
  Carolina Frías MD, Ricardo Lauzurica MD.
  Department of Microbiology; Department of Nephrology, Kidney Transplant Unit.
  Hospital Universitari Germans Trias i Pujol, Badalona
  Barcelona. Spain


OTHERS

• MICROALBUMINURIA SIGNO Y ELEMENTO CAUSANTE DE PROGRESION DE LA ENFERMEDAD RENAL
  Dra. Stella M. Dieguez
  Hospital de Niños Dr. Ricardo Gutierrez
  Buenos Aires. R. Argentina

• INFORMATICS & NEPHROLOGY
  Yousef A. Boobes, MD
  Head Renal Division. Tawam Hospital, Al Ain
  Dubai. A.Emirates

• HOLISM AND MEDICINE
  
• HOLISMO E MEDICINA
  Prof. Helio Teixeira
  Universidade Federal de Uberlandia. Brazil